 Hey guys, how you doing? This is Rich from Rich City Live. Another pic that I wanted to bring to your attention and I got to give it up to MC because she's just like AYTU, AYTU, AYTU is AYTU on the NASDAQ, AYTU Bioscience. It was at $1.36 up 4%. Now at $1.48 up 8% after market. I think that they could fly on Monday. They could go much higher because the US right now is really focused on test kits. These guys are working in the test kit business. Look at this news right here. ITU Bioscience Inc. AYTU, a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today that it extended its distribution rate to commercialize the clinically validated and commercially used coronavirus 2019 COVID-19 IgG IgM rapid test. The test has been licensed from LB Resources, Limited, a Hong Kong corporation. The COVID-19 IgG IgM rapid test is intended for personal use and delivers clinical results between two and ten minutes at the point of care. This amendment expands ITU's commercial rights and grants ITU the right to distribute and commercialize the COVID-19 test in North America. That is a game changer. Game changer. Specifically including the United States, which obviously is in big need right now, Canada and Mexico. The company expects to pursue expedited regulatory clearance of the product with Health Canada and COFFEBRIS, Commission, Federal, Para, La, Protection, Contra, RIGOS, Sanitarios, the regulatory agencies in Canada and Mexico respectively. Josh Dizbrough, Chief Executive Officer of ITU Bio and Science commented, we have to be progressive in doing our part in combating the spread of the COVID-19 virus. We need to ensure the screening is available across North America and providing broad access to screening tests has to be among our highest priorities as we collectively fight the coronavirus outbreak. With COVID-19 now designated as a global pandemic, we believe we should expand our efforts to assist healthcare providers with faster point-of-care detection. The COVID-19 IgG backslash IgM rapid test is a solid phase immunochromatographic assay used in the rapid qualitative and differential detection of IgG and IgM antibodies to the 2019 novel coronavirus in human whole blood, serum or plasma. This point-of-care test has been validated in 113 patient clinical trial and is CE marked. Huge news, big news, ITU Bioscience Inc. I'm not gonna get into all of it. Do your research, do your due diligence. If you like this video, smash the like button, comment down below, share the video everywhere. I want to know do you think this is the next big winner? I'm gonna show you something. In the last three months, the stock has gone bonkers. I mean, it's been as high as what? What's like they're high here? I know it's higher than this. I think it's been as high as four or five bucks, guys. It says $2.99, but I know it's been higher than this. Probably finished the day at $2.99, but intraday, it's been as high as four or five bucks. Like this thing has screamed. Came back down, created a buying opportunity, and I think right now is a good time to pick it up. And that's why I think it's going up. And it went up 8% aftermarket on Friday, which is a good sign that we could see it explode on Monday. Keep it on your watch list. Keep it on your radar. We bring you the winners and we bring them to you first. I2 Bioscience. Test kits, two to 10 minutes, Canada, United States, Mexico. Your boy, Richard, must be live. If you ain't winning, you ain't watching. It's true. It's your boy, and I'm out. Peace.